FDA Update: BIMO - What Sponsors Need to Know
The FDA’s Bioresearch Monitoring (BIMO) program is implemented to ensure the protection of the rights, safety, and welfare of human research subjects and to ensure the accuracy and reliability of clinical trial data. The FDA’s Office of Regulatory Affairs (ORA) Office of Bioresearch Monitoring conducts inspections related to FDA regulated research. The agency recently updated the compliance program governing inspections of sponsors and CROs. This may mean operational resets for sponsors and CROs, as well as prompt the need to update inspection readiness programs. This webinar highlights key changes to the compliance program for sponsors and CROs and gives tips and best practices for companies to consider when preparing:
- For regulatory inspections
- To host a sponsor/CRO inspection
- For changes to governance expectations—vendor management and oversight
Presented By
Joan Versaggi
MBA
Principal, Consulting Quality CoE
Advarra
Leslie Paul
MS
Director, Consulting Quality COE
Advarra
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
DATE: June 17, 2021
Time: 1 pm ET | 10 am PT
Duration: 1 hour